318 results
8-K
EX-1.1
BMY
Bristol-Myers Squibb Co.
22 Feb 24
Other Events
4:15pm
of any claim under any environmental laws and the Company is not aware of any pending investigation that could reasonably be expected to lead … by such indemnified party, in connection with the defense thereof other than reasonable costs of investigation. Notwithstanding the foregoing
8-K
EX-5.1
BMY
Bristol-Myers Squibb Co.
22 Feb 24
Other Events
4:15pm
having made any special investigation as to the applicability of another statute, law, rule or regulation. None of the opinions or other advice contained
424B5
BMY
Bristol-Myers Squibb Co.
16 Feb 24
Prospectus supplement for primary offering
4:34pm
on our experience in the industry and our own investigation of market conditions. We believe these estimates to be accurate as of the date
424B2
y832vhc1hbk80wa8cn3
13 Feb 24
Prospectus for primary offering
8:00am
SC TO-T
EX-99
gamq0f6sh39mh p1
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
6av14k
25 Jan 24
Third party tender offer statement
8:13am
8-K
EX-1.1
hbz57ssf9 87x7
13 Nov 23
Other Events
4:19pm
8-K
EX-5.1
erwtx94y4
13 Nov 23
Other Events
4:19pm
424B5
v4x5qokpyo2y
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
5fquedwahjkp4sfsj4s
30 Oct 23
Prospectus supplement
8:05am
DEFA14A
r6is571in6z1ns6u12
10 Apr 23
Additional proxy soliciting materials
5:12pm